Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-34
Closed 2629
2016
Q4
$0 Hold
34
﹤0.01% 2612
2016
Q3
$0 Hold
34
﹤0.01% 2603
2016
Q2
$0 Sell
34
-6,861
-100% ﹤0.01% 2494
2016
Q1
$152K Sell
6,895
-1,853
-21% -$40.8K ﹤0.01% 952
2015
Q4
$241K Sell
8,748
-87
-1% -$2.4K 0.01% 781
2015
Q3
$226K Sell
8,835
-169
-2% -$4.32K 0.01% 783
2015
Q2
$221K Buy
9,004
+2,072
+30% +$50.9K 0.01% 839
2015
Q1
$173K Sell
6,932
-316
-4% -$7.89K 0.01% 923
2014
Q4
$168K Sell
7,248
-1,154
-14% -$26.7K 0.01% 935
2014
Q3
$189K Buy
8,402
+7,344
+694% +$165K 0.01% 886
2014
Q2
$25K Buy
1,058
+20
+2% +$473 ﹤0.01% 1597
2014
Q1
$21K Sell
1,038
-21
-2% -$425 ﹤0.01% 1633
2013
Q4
$24K Buy
1,059
+52
+5% +$1.18K ﹤0.01% 1512
2013
Q3
$21K Sell
1,007
-4
-0.4% -$83 ﹤0.01% 1333
2013
Q2
$20K Buy
+1,011
New +$20K ﹤0.01% 1303

Other funds holding QGENF

D.A. Davidson & Co's QGENF Position: Q1 2017 in Review

D.A. Davidson & Co sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 34 shares.

D.A. Davidson & Co first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $241K in Q4 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • D.A. Davidson & Co reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 34 QIAGEN NV shares in Q1 2017.
  • D.A. Davidson & Co first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • D.A. Davidson & Co's QIAGEN NV position peaked at $241K in Q4 2015.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on D.A. Davidson & Co's 13F filing for Q1 2017, filed 12 May 2017.